Literature DB >> 1583330

T lymphocyte subsets during and after pregnancy: analysis in human immunodeficiency virus type 1-infected and -uninfected Malawian mothers.

P G Miotti1, G Liomba, G A Dallabetta, D R Hoover, J D Chiphangwi, A J Saah.   

Abstract

Flow cytometric studies were done in Malawi on 229 women in their third trimester and 128 women 6 weeks postpartum; both human immunodeficiency virus type 1 (HIV-1)-seropositive and -seronegative women demonstrated an increase in the absolute number of CD4 and CD8 lymphocytes between late pregnancy and early postpartum, while percentages of CD4 and CD8 cells remained virtually unchanged. Subsequent measurement of CD4 and CD8 cells 6 weeks after delivery in 89 women tested in the third trimester showed an increase in absolute numbers in both HIV-1-seropositive and -seronegative women, without a parallel increase in CD4 or CD8 percentage. Regardless of HIV-1 infection status, Malawian women are no more immunosuppressed, as measured by T cells, in their third trimester of pregnancy than in the nonpregnant state. Percentage, rather than absolute number, should be used when monitoring CD4 and CD8 cell levels in pregnant women to avoid the effect of higher volume of distribution on absolute numbers of T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583330     DOI: 10.1093/infdis/165.6.1116

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Postpartum plasma CD4 change in HIV-positive women: implications for timing of HAART initiation.

Authors:  Ai Koyanagi; Andrea J Ruff; Lawrence H Moulton; Robert Ntozini; Kuda Mutasa; Peter Iliff; Jean H Humphrey
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

2.  Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural Rwanda.

Authors:  Philip L Bulterys; Ann Chao; Sudeb C Dalai; M Christine Zink; Abel Dushimimana; David Katzenstein; Alfred J Saah; Marc Bulterys
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

3.  Pregnancy outcomes in women with advanced HIV infection in Italy.

Authors:  Silvia Baroncelli; Enrica Tamburrini; Marina Ravizza; Carmela Pinnetti; Serena Dalzero; Manuela Scatà; Alessandra Crepaldi; Giuseppina Liuzzi; Atim Molinari; Antonella Vimercati; Anna Maccabruni; Daniela Francisci; Elena Rubino; Marco Floridia
Journal:  AIDS Patient Care STDS       Date:  2011-09-23       Impact factor: 5.078

4.  Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study.

Authors:  A Achiron; Z Rotstein; S Noy; S Mashiach; M Dulitzky; R Achiron
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

5.  Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery.

Authors:  Risa M Hoffman; Erin Leister; Deborah Kacanek; David E Shapiro; Jennifer S Read; Yvonne Bryson; Judith S Currier
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

6.  Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women.

Authors:  Elizabeth R Brown; Phelgona Otieno; Dorothy A Mbori-Ngacha; Carey Farquhar; Elizabeth M Obimbo; Ruth Nduati; Julie Overbaugh; Grace C John-Stewart
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

7.  Leukocyte counts and lymphocyte subsets in relation to pregnancy and HIV infection in Malawian women.

Authors:  Wilson L Mandala; Esther N Gondwe; Malcolm E Molyneux; Jenny M MacLennan; Calman A MacLennan
Journal:  Am J Reprod Immunol       Date:  2017-04-06       Impact factor: 3.886

8.  Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus.

Authors:  N L Eriksen; A W Helfgott
Journal:  Infect Dis Obstet Gynecol       Date:  1998
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.